One type of mammogram proves better for women with dense breasts
Advertisement
'Contrast-enhanced mammography needs to become standard of care for women with dense breasts,' if they are at high risk of developing breast cancer, said Dr. Fiona J. Gilbert, a professor of radiology at the University of Cambridge's School of Clinical Medicine. She is lead author of the study, which was published Wednesday in The Lancet.
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
Tumors typically show up as white spots on mammograms, but dense breast tissue also appears white, obscuring the tumors.
'When you have lots of white normal breast tissue, it's hard to see the white cancers,' Gilbert said. 'But when you do the contrast, the cancers take up the iodine, and all you're seeing is this cancer lighting up.'
A large Dutch study published in 2019 showed that MRIs are more effective than standard mammography at finding tumors in dense breast tissue. The new study is the first randomized controlled clinical trial to compare MRIs, ultrasounds, and contrast-enhanced mammography in women with dense breast tissue.
Advertisement
JoAnn Pushkin, executive director of the educational group DenseBreast-info, said the study showed that contrast-enhanced mammograms could save lives. They not only found more tumors, but also detected them when they were small and had not yet spread to the lymph nodes.
'This means these cancers were found early enough that most were still contained within the breast,' Pushkin said. 'These were tragedies averted. If they had not been found, they would have grown undetected until they were horror stories.'
But while contrast-enhanced mammography is available in some centers in the United States, its use for breast cancer screening has not been approved by the Food and Drug Administration. (It is more often used as a diagnostic tool after suspicious findings appear on a regular mammogram.)
Partly that's because of concern over allergic reactions to the contrast agent, which are uncommon but can be severe, according to Dr. Wendie Berg, a professor of radiology at the University of Pittsburgh School of Medicine and chief scientific adviser to DenseBreast-info.
Gilbert, the study's lead author, also cautioned that while extra imaging can lead to earlier detection in women with dense breasts, it may also increase overdiagnosis and overtreatment of a medical condition that may never become life-threatening if left alone.
Yet most of the tumors detected with the contrast-enhanced scans actually were invasive and potentially life-threatening, Berg said. These cancers show up more readily when dye is used.
Contrast-enhanced mammograms are more cost-effective than MRI scans, and they could be made more widely available at existing mammography centers with staff training and sometimes technology upgrades, Pushkin said.
Advertisement
The new study, carried out at 10 screening sites in the United Kingdom between Oct. 18, 2019, and March 30, 2024, was the kind of trial considered the gold standard in medicine.
More than 9,000 women aged 50 to 70 who had dense breast tissue and normal mammograms were randomly assigned in roughly equal numbers to receive standard digital mammography, MRIs, ultrasounds, or contrast-enhanced mammography. About 6,305 completed the additional imaging tests.
MRI scans turned up 17.4 cancers per 1,000 exams, while ultrasounds found only 4.2 cancers per 1,000 exams. Contrast-enhanced mammograms detected 19.2 cancers per 1,000 exams, but the difference between MRI and contrast-enhanced mammography was not statistically significant.
Not all of the tumors were invasive. MRIs revealed 15 invasive cancers per 1,000 exams, ultrasounds found 4.2 invasive cancers per 1,000 exams, and contrast-enhanced mammography detected 15.7 invasive cancers per 1,000 exams.
Most of the cancers were less than 2 centimeters in size, and had not spread to the lymph nodes.
There were adverse events associated with the use of iodine dye. Twenty-four patients who underwent contrast-enhanced mammograms had reactions, and three experienced so-called extravasation, in which the dye leaks out of blood vessels into adjacent tissue.
There were no adverse events associated with ultrasound, and there was one case of extravasation among the women who received MRIs, in which contrast dye is sometimes used.
Among the trial participants whose cancer was discovered during a supplemental MRI was Louise Duffield, 60, who lives in Ely, near Cambridge.
Duffield was invited to participate in the trial in 2023, after her regular mammogram screening showed that she had very dense breasts. When she came in for an extra MRI, the scan identified a small lump.
Advertisement
A biopsy determined that the tumor was Stage 0, or very early, and confined within the milk ducts. Duffield had surgery to remove the tumor six weeks later, by which time it had already grown larger than it had appeared on the scans, hospital officials said.
Because of the location of the tumor, Duffield would have had difficulty identifying it with a self-exam. And since the tumor was not detected during her regular mammogram, she would not have had to come in for another scan for at least three years, based on UK guidelines.
Duffield was treated with radiation and is now free of cancer. 'The tumor was deep in the breast, so if I hadn't been on the trial, it could have gone unnoticed for years,' Duffield said in a statement. 'Without this research, I could have had a very different experience.'
This article originally appeared in
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
a day ago
- UPI
Developmental impairments in kids linked to pesticide exposure
Columbia University researchers said exposure to common pesticide chlorpyrifos during pregnancy can impair children's brain development and motor function for years to come. Photo by Adobe Stock/HealthDay News Exposure to a common pesticide during pregnancy can impair children's brain development and motor function for years to come, a new study says. The widely used pesticide chlorpyrifos is linked to altered brain function and poorer fine motor control among children exposed to it while in the womb, researchers report in JAMA Neurology. "The disturbances in brain tissue and metabolism that we observed with prenatal exposure to this one pesticide were remarkably widespread throughout the brain," lead researcher Dr. Bradley Peterson said in a news release. He's chief of child and adolescent psychiatry at the University of Southern California's Keck School of Medicine. For the study, researchers conducted behavioral assessments and MRI scans of 270 kids in upper Manhattan whose mothers had been exposed to CPF during pregnancy when their apartments were fumigated. These assessments occurred between 1998 and mid-2005. The U.S. Environmental Protection Agency banned CPF for residential use in 2001, but it's still used as an agricultural pesticide for non-organic fruits, vegetables and grains such as apples, strawberries, asparagus, tart cherries, citrus and peaches, researchers noted. CPF is an organophosphate pesticide, in the same chemical family as nerve gas, researchers note. The chemical can cross the placenta to the fetus, and easily traverse the fetal blood-brain barrier. CPF has been used to control cockroaches, fleas and termites, and has been an active ingredient in some flea and tick collars for pets, according to the Agency for Toxic Substances and Disease Registry. The MRI scans revealed that the children had specific changes in their brain's cortex, white matter, network pathways and nerve insulation, all of which could impair development, motor control and brain function. Further, progressively higher exposure to CPF was significantly associated with increasingly greater alterations in brain structure and function, as well as poorer motor function, researchers said. "More CPF exposure led to more thickening of the cerebral cortex -- the area of the brain that directs functions like thinking, memory and movement," Peterson said. "We don't know the consequences of these brain effects, but we found that CPF exposure most impairs motor functioning." The data strongly suggest that CPF exposure affects the way that neurons develop, Peterson said. "That happens early in pregnancy, when neurons develop in the cortex and differentiate into cortical gray matter -- densely packed nerve cells which process information -- and underlying white matter -- which is mostly nerve fibers that connect neurons," Peterson said. "All these abnormalities can contribute to poor motor function in these kids," he continued. "The contributing mechanisms seem to be the inflammation and oxidative stress that CPF and other pesticides produce." Results also showed that children exposed to CPF had dramatically reduced blood flow to the brain. "To me, this is the most profound finding because it's so powerful and very rare to see something like this," Peterson said. "Blood flow is an important indicator of underlying metabolism -- the energy used by brain tissue. In my opinion, it's maybe the most important finding of the paper, because it says that globally there's a problem with brain metabolism in direct proportion to how much CPF exposure they had." Toxic exposure to CPF continues to be a risk during pregnancy, either through the food supply or from outdoor air and dust near farmland, researchers said. "Current widespread exposures, at levels comparable to those experienced in this sample, continue to place farm workers, pregnant women and unborn children in harm's way," senior researcher Virginia Rauh said in a news release. She's a professor of population and family health at Columbia University Mailman School of Public Health in New York City. "It is vitally important that we continue to monitor the levels of exposure in potentially vulnerable populations, especially in pregnant women in agricultural communities, as their infants continue to be at risk," Rauh added. Peterson said pregnant women also should be wary of potential exposure through produce. "It's in our food supply," he said. "And other chemicals used in the home act in similar ways and almost certainly increase inflammation and oxidative stress. This is why it is important to do these studies about the chemicals in our environment to protect children's health." More information The U.S. Environmental Protection Agency has more about chlorpyrifos. Copyright © 2025 HealthDay. All rights reserved.
New York Post
a day ago
- New York Post
I had breast cancer at 24 — now I'm already going through menopause
Mood swings. Hot flashes. Night sweats. They're symptoms most women expect in middle age, not when you're barely old enough to rent a car. But Alexis Klimpl was just 25 when the brutal reality of premature menopause struck. A year ago, though, she faced an even tougher battle — and was unsure if she'd live long enough to go through the so-called 'change of life' at all. Advertisement 9 Alexis Klimpl is a publicist based in San Diego, Calif. Courtesy Alexis Klimpl A lump and a life-changing call Lying in bed at home in San Diego one night last July, Klimpl reached down to scratch an itch — but her hand froze as her fingers brushed against a small, hard lump on her right breast. 'I shot up and looked over at my boyfriend, and my face just dropped,' she told The Post. Advertisement Her mind ran through the possibilities: fibrous tissue, a cyst, maybe even a benign tumor. But lurking in the back of her mind was a thought she couldn't shake: breast cancer. In 2025, the American Cancer Society estimates that 316,950 women in the US will be diagnosed with the disease — yet only a small fraction of these cases occur in women under 45. Even fewer are as young as Klimpl, then just 24. Her thoughts quickly turned to her father, who had died of bile duct cancer at 67. 9 Klimpl credits the support of her family and friends as a major bright spot in her cancer journey. Courtesy Alexis Klimpl Advertisement But Klimpl didn't get it checked out immediately. Days later, she left for a three-week surfing trip to Indonesia to chase waves her father had introduced her to as a young girl. 'I wasn't going to cancel that for anything,' she said. The lump was the size of a Skittle when she left. When she returned less than a month later, it had grown to the size of a grape. 'We always think that we're going to be young and healthy forever, and that's just not the case.' Alexis Klimpl Advertisement Alarmed, her doctor ordered a mammogram and biopsy. She then got a call asking her to come in the next day to discuss the results, sending her into a panic. 'I was spiraling,' she recalled. 'What if it's terminal? What if it's growing faster than we can start chemo? What am I going to do about work? Oh god, am I going to be able to have kids one day?' The next morning, her worst fears were confirmed: The lump was Stage 1 triple positive breast cancer. Two weeks later, an MRI showed it had advanced to Stage 2. 9 Concerned about chemotherapy negatively affecting her fertility, Klimpl froze her eggs before starting treatments. Courtesy Alexis Klimpl Facing the future Doctors warned her that chemotherapy could threatened her ability to have children naturally — and hormone injections to stave off future cancer could send her into early menopause — so she met with a fertility specialist who recommended freezing her eggs. What followed was a 'brutal process' that took over her entire August, what Klimpl calls 'one of the hardest parts of this whole journey.' Even after egg retrieval, she was laid up for two weeks, unable to move from the abdominal soreness. The goal was 20 eggs. Doctors got 36. Coping with chemo Advertisement Eggs frozen, Klimpl, a publicist, began six rounds of chemotherapy. To try to save her hair, she did cold capping, a treatment that cools the scalp to about 37°F, reducing blood flow and making hair follicles less vulnerable to the drugs. 9 Klimpl's chemotherapy treatments were stretched out over the span of three months. Courtesy Alexis Klimpl But the frozen headgear — worn before, during and after infusions — brought its own side effects, including headaches, chills, dizziness and scalp pain. Advertisement 'I remember always thinking, this time I'm going to be strong, but then [the cap] touches you, and like a flip of a switch, you just absolutely lose it in front of a room full of strangers,' she said. 'It was hard seeing people my age going out and having fun, meeting new people. My life was on pause.' Alexis Klimpl She ended up losing about 30% of her hair — and though she wondered if she'd have been better off shaving her head, she knew being bald, on top of everything else, 'probably would have broken me.' The rest of Klimpl's chemo was milder than expected, with fatigue, body aches and a rash — though the queasiness tested her. Advertisement 9 Cold capping, also known as scalp cooling, helped Klimpl preserve most of her hair while going through chemotherapy. Courtesy Alexis Klimpl 'This nausea was in my bones,' Klimpl recalled. 'I felt it all over my body. It was always there, every single day, for 4½ months.' But the hardest part was being cut off from the ocean — her main source of stress relief — since the salt water could interfere with her cold cap treatments. Advertisement 'My dad was the person who taught me how to surf, and that's how I've always felt most connected to him, so it was pretty emotionally dark for me,' Klimpl said. She also felt isolated. The young survivor group at her hospital mostly included women in their 40s and 50s, many married with kids. 'It was hard seeing people my age going out and having fun, meeting new people,' she said. 'My life was on pause.' 9 Klimpl is a lifelong surfer, and the hope of returning to the ocean kept her motivated through her treatments. Courtesy Alexis Klimpl Surgery, sacrifice and survival Klimpl finished chemotherapy in December. Her tumor had shrunk significantly. Soon after, she faced a tough series of surgeries: tumor removal in late January, a double mastectomy a week later and breast reconstruction in May. The decision to remove both breasts wasn't easy. 'If you get a double, you lose feeling in all of your chest and you can't breastfeed your kid,' Klimpl said. Still, the fear of recurrence lingered. 9 By freezing her eggs before going through chemotherapy, Klimpl hopes to have children naturally in the future. 'My turning point was realizing I needed to do this for myself,' she said. 'Not for the kid I don't even have yet.' Right before her second surgery, as anesthesia took hold, her surgeon told her she was in remission. Hormones and hardships Over the next year, Klimpl will get hormone infusions to lower the risk of cancer returning. For the following decade, she'll take a daily pill that stops her ovaries from producing estrogen to reduce the chance of recurrence even further. 9 Klimpl's loved ones rallied around her at diagnosis and came together to celebrate her remission. Courtesy Alexis Klimpl The treatment pushed her into menopause decades early, bringing a host of uncomfortable symptoms. 'I have hot flashes, like, 20 times throughout the day,' she said, noting that she also struggles with insomnia, joint pain, vaginal dryness and mood swings. 'I'm depressed one day, I'm over the moon the next, and then I'm just numb,' Klimpl said. Strength in struggle Despite everything, Klimpl is holding onto hope for the future. 9 Klimpl was able to return to the ocean in July 2025 — roughly a year after her cancer diagnosis. 'I know I've always been a really strong person because of what I've gone through, but this has taught me that the sky is limitless with what I can do,' Klimpl said. It also shifted her perspective on life itself. 'We always think that we're going to be young and healthy forever, and that's just not the case,' she added. Before her diagnosis, her mom would tell her 'I love you' countless times a day. While she appreciated the affection, she admitted it could sometimes feel a bit much — especially when the messages popped up during work hours. 'She'd always say, 'You never know when the last time is going to be,' and I would always get mad at her for saying that,' Klimpl remembered. 'But now I'm like, damn, she knew all along.'
New York Post
2 days ago
- New York Post
Mom's brain tumor caused her to ‘forget' she had a son: ‘That was heartbreaking'
A UK woman says her brain tumor made her 'forget' she was a mom — after flashing lights and rainbow-like patterns in her vision led to her diagnosis. Clare Smerdon, 37, was diagnosed with a grade 4 astrocytoma — just weeks after her son Teddy turned 13 months. Advertisement Doctors told her the aggressive tumor was life-limiting, and Clare feared she would never get to watch Teddy grow up. While waiting for surgery to remove the tumor she says she was 'acting completely out of character' and 'forgot I was a mum.' 5 UK mom Clare Smerdon was diagnosed with a brain tumor just 13 months after giving brith to her son Teddy. Brain Tumour Research / SWNS But two years on, she has defied the odds and proudly watched her son, now four, put on his uniform and walk through the gates of Barton Hill Academy for his first day of school. Advertisement Clare from Torquay, Devon, said: 'When I received my diagnosis, I didn't think I'd be alive today to see Teddy start school. 'This is such a huge milestone for us. 'I no longer feel like I am dying and feel incredibly lucky, but I know others may not get the same chance.' 5 Clare's scar from her brain tumor surgery. Brain Tumour Research / SWNS Advertisement Clare's symptoms first appeared in early 2022, when she began experiencing flashing lights and rainbow-like patterns across her vision. She said: 'I felt as though people didn't understand what I was going through. I was desperate to find out what was causing the immense pain in my head and changes in my vision.' Clare had an MRI scan at Derriford Hospital in Plymouth which revealed a 2.75 inch brain tumor in July 2022. She said: 'When I got the diagnosis I remember thinking that I'd just had a baby, and I wanted to be around to watch my son grow up for as long as I could. Advertisement 5 The tumor caused Clare to see flashing lights and even forget that she was a mother. Brain Tumour Research / SWNS 'Then the wait for surgery was horrendous. I was losing myself and acting completely out of character. 'I even forgot I was a mum. Teddy spent more time with his dad, and we drifted apart. That was heartbreaking.' In August 2022, Clare underwent a six-hour operation to remove the tumor followed by six weeks of radiotherapy and chemotherapy. She said: 'Two weeks after surgery I returned home, and doctors confirmed I had a grade 4 astrocytoma which is also classified as a glioblastoma. 'On hearing the pathology results I knew my life was over. The treatment made me sick, and I could only stomach a meal in the evening. 5 Clare was told in 2023 that she would only have two to three years to live. Brain Tumour Research / SWNS 'At the same time, I got to spend more time with Teddy, and we were both getting to know each other again.' Advertisement A routine scan in August 2023 revealed she had just two to three years to live. Clare said: 'The thought of not being here to watch Teddy grow is destroying. I'm not sure if another operation is something I want due to the implications that comes with it. 'My eyesight is already compromised, and my speech has been impacted, so now I just watch and wait. 'There are so few treatment options for brain tumor patients, and the ones we do have are invasive and often life changing. Advertisement 5 Clare participating in a charity walk to raise money for brain tumor research. Brain Tumour Research / SWNS 'I've looked into clinical trials abroad, but for most working-class families, the cost is impossible. I'm angry and frustrated at how little support and research funding there is.' Clare is now working with Brain Tumour Research and will take part in the charity's Walk of Hope in September. She said: 'I want to do everything I can to help fund the research that will lead to better treatments and, ultimately, a cure. Advertisement Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more. Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters 'If sharing my story and taking part in fundraising encourages even one more person to join the cause, it will be worth it. 'That's why I'm calling on the government to increase funding for research into brain cancer, more must be done.' Letty Greenfield, community development manager at Brain Tumour Research, said: 'Clare's story is a powerful reminder of both the personal impact of a brain tumor diagnosis and the urgent need for change. Advertisement 'We are so inspired by her strength and determination. Brain Tumour Research is committed to funding sustainable research at our dedicated Centres of Excellence, but we also campaign for the government to increase funding. 'It's only through increased investment that we can accelerate new treatments and, ultimately, find a cure.' Brain Tumour Research is calling for a national annual spend of $47.2 million to bring brain cancer funding in line with other cancers such as breast cancer and leukemia. A JustGiving page has been set up by Clare to help raise money for Brain Tumour Research ahead of the Walk of Hope in September.
